Skip to main content
Clinical Trials/CTRI/2018/03/012267
CTRI/2018/03/012267
Not yet recruiting
未知

Genzyme Rare disease registries (Pompe Disease Registry Protocol)

Sanofi Synthelabo India Private Limited0 sites0 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Health Condition 1: E740- Glycogen storage diseaseHealth Condition 2: null- Pompe Disease
Sponsor
Sanofi Synthelabo India Private Limited
Status
Not yet recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Observational

Investigators

Sponsor
Sanofi Synthelabo India Private Limited

Eligibility Criteria

Inclusion Criteria

  • 1\.All age group from new born to old age allowed.
  • 2\. All patients with a confirmed diagnosis of Pompe disease who are willing and able to provide written informed consent and any additional authorization documents required by local law to send health information to the Registry are eligible for inclusion, regardless of whether they are receiving disease therapy including ERT (such as alglucosidase alfa) and irrespective of the commercial product with which they are being treated.
  • 3\. A confirmed diagnosis is defined as documented acid α\-glucosidase (GAA) enzyme deficiency from blood, skin, or muscle tissue and/or documentation of 2 GAA gene mutations.

Exclusion Criteria

  • No Exclusion Criteria

Outcomes

Primary Outcomes

Not specified

Similar Trials